| Shed | Compounded semaglutide injections advertised from $199/month as of mid-2026, where still offered (subject to current FDA compounding restrictions) | Compounded semaglutide and tirzepatide injections and lozenges, plus Wegovy, Zepbound, and Foundayo by eligibility | Moderate | Needle-averse users, guarantee seekers, and budget-conscious cash-payers |
| Embody GLP1 | Compounded semaglutide $49/month and tirzepatide $99/month, an advertised sale price, flat per medication (checked 28 Oct 2026) | Injectable semaglutide, injectable tirzepatide, and GLP-1 gum | Moderate to high | Users who want a flexible GLP-1 start with modern telehealth support |
| Sprout Health | Program pricing varies by treatment path | GLP-1, non-GLP-1 weight-loss, and NAD+ pathways vary by eligibility | Moderate | Users who want a broader telehealth weight-loss and wellness comparison |
| MEDVi | $99 for the first month, an introductory price, then $199 for refills (checked 28 Oct 2026) | GLP-1 medication access depends on review and eligibility | Moderate | Users comparing carefully on cost and access |
| Fridays | Tirzepatide as low as $198 a month (checked 28 Oct 2026) | GLP-1 medication program with structured support | High | Users who want more guidance and clearer pricing structure |
| Ro | From $39 membership; eligible plans from $149/month | Brand-name and broader access paths vary by eligibility | Moderate | Users who value familiarity and brand trust |
| Trim Rx | GLP-1 plan from $179, GLP-1 + GIP plan from $259 (all-inclusive) | Compounded GLP-1 and GLP-1 + GIP plans; a provider may instead prescribe a branded medication, which is filled at your own pharmacy | Moderate | Cash-pay users who want all-inclusive pricing that stays steady as the dose changes |
| Willow | Semaglutide $299/mo and tirzepatide $399/mo, each as a weekly injection or a daily tablet; NAD+ $199/mo (checked September 2026) | Compounded semaglutide and compounded tirzepatide, each as a weekly injection or a daily sublingual tablet; NAD+ also offered | High | Users who want a choice of treatment route rather than the cheapest entry price |
| welludr (formerly Wellmedr) | From $41 a month for semaglutide and $71 a month for tirzepatide during its fall sale, checked 28 Oct 2026. The plan cards say Starting At and the final price is confirmed at checkout. | Compounded semaglutide and compounded tirzepatide; branded options are also offered | Messaging with clinicians and ongoing check-ins included; a clinician decides on treatment | People who want a published starting price and accept that the sale price is promotional |